MRC Laboratory of Molecular Biology

Name

MRC Laboratory of Molecular Biology

Legal name

MRC Laboratory of Molecular Biology

Website

https://www2.mrc-lmb.cam.ac.uk

Company type

Private

Founded year

1947

Operating status

Operating

Headcount range

5,001–10,000 employees

Ownership category

akta.pro rank

Headquarters

HQ city

Cambridge

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Infrastructure, Operations, Others

Revenue model

1. Core Government Funding: The LMB receives generous core-funding from the Medical Research Council (MRC), which is part of UK Research and Innovation (UKRI). This provides stable base funding for fundamental research operations.
2. Commercialization and Licensing: Discoveries from LMB research have led to highly successful commercialisations. The Achievements page specifically mentions 'Commercial Activities' as a section, indicating active commercialization of research outputs through licensing, patents, and spin-out companies.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Core offering

The MRC Laboratory of Molecular Biology (LMB) is a publicly funded fundamental research institute dedicated to understanding biological processes at atomic, molecular, cellular, and organismal levels. It pursues ambitious research across over 50 scientific groups using cutting-edge facilities such as cryo-electron microscopy, computational protein design, and brain connectomics. Outputs are disseminated to the global scientific community through open-access publications, open-source scientific software, training seminars, and technology commercialisation through licensing and spin-out companies.

Product overview

The MRC Laboratory of Molecular Biology (LMB) is a fundamental research institute dedicated to understanding biological processes at atomic, molecular, cellular, and organismal levels. The LMB comprises over 50 scientific groups pursuing research across multiple divisions, supported by cutting-edge scientific facilities including cryo-EM, electron microscopy, and other advanced imaging technologies. As a research institution rather than a commercial product company, LMB's offerings include published scientific research, training seminars, and the LMB Developed Software collection of research tools.

Differentiator

Problem solved

Functional benefit

Products and services

• LMB Developed Software A collection of open-source scientific software tools developed by LMB researchers and shared with the global scientific research community, including tools such as SpineDL and SAMJ (Segment Anything Model for ImageJ/Fiji). The tools are made freely available for use in biological and biomedical research workflows.

Quantifiable outcome

• Discoveries have led to highly successful commercialisations and medical advances that have improved human life
• +1 more outcomes

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Six partnerships are on record, tiered major.

• University of WashingtonmajorStrategic or Co-development PartnerInternational research collaboration partner in the development of novel designer fluorescent proteins with near-infrared and short-wave infrared spectra capabilities.
• Howard Hughes Medical InstitutemajorStrategic or Co-development PartnerCollaborating institution in the international research team developing novel fluorescent proteins using computational protein design.
• German Cancer Research Center (DKFZ)majorStrategic or Co-development PartnerKey collaboration partner in cancer research including the National Center for Tumor Diseases Dresden for developing fluorescent proteins with applications in cancer detection during surgery.
• FlyWire ConsortiummajorStrategic or Co-development PartnerInternational consortium focused on whole-brain connectome mapping, involving LMB researchers led by Greg Jefferis.
• École Polytechnique Fédérale de Lausanne (EPFL)majorStrategic or Co-development PartnerPartner institution for the annual LMB-EPFL Graduate Life Sciences Symposium, fostering graduate-level scientific exchange.
• National Center for Tumor Diseases DresdenmajorStrategic or Co-development PartnerLed by Professor Oliver Bruns, this institution collaborated on developing novel near-infrared fluorescent proteins for biomedical applications including cancer surgery and disease monitoring.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Wellcome Sanger Institute: Cambridge-based genomics research institute funded by Wellcome; directly comparable in location, scale and a major UK centre for molecular/genomic biology with active technology transfer and spin-out activity.
• Scripps Research: US non-profit research organization with deep structural biology, chemistry and immunology programmes; directly comparable in fundamental-discovery mission and technology-transfer output.
• Broad Institute of MIT and Harvard: US genomic medicine and chemical biology institute with overlapping strengths in structural biology, CRISPR/functional genomics, and large-scale data platforms; a global benchmark for academic-to-commercial translation.
• Salk Institute for Biological Studies: California-based basic-research institute working on molecular and cellular biology with a comparable small-group, high-impact-discovery model and a history of technology commercialization.
• Francis Crick Institute: London-based biomedical discovery institute with comparable scale (~1,500+ scientists), UK government/core-funding model, and broad molecular biology remit; the closest UK peer to LMB in mission, funding profile, and translational pipeline.
• Rockefeller University: US graduate-research university with Nobel-rich tradition of small-lab molecular/cell biology; comparable in scale, talent density and historical commercialization of basic discoveries.
• European Molecular Biology Laboratory (EMBL): Intergovernmental European molecular biology research organization with structural biology, bioinformatics, and instrumentation programmes directly comparable to LMB's cryo-EM and software work.
• Howard Hughes Medical Institute (HHMI) Janelia Research Campus: HHMI's research campus shares LMB's model of small group-driven, technology-intensive fundamental biology (imaging, connectomics, tool-building) and is a named LMB collaboration partner.
• Whitehead Institute for Biomedical Research: MIT-affiliated biomedical research institute with a similar small-group structure, focus on fundamental molecular/cell biology, and an active spin-out and licensing track record.
• Max Planck Institute for Molecular Cell Biology and Genetics: German basic-research institute pursuing molecular cell biology with quantitative imaging and model-organism approaches; comparable in scientific scope and core-funding model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/MRC_LMB
• LinkedInlinkedin.com/company/mrc-laboratory-of-molecular-biology

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MRC Laboratory of Molecular Biology